Q4 2024 Earnings Call Transcript March 7, 2025 Operator: Good morning, and welcome to the Molecular Partners Fourth Quarter ...

Before diving into the highlights '24, we did put on the 20 years Molecular Partners logo because it is our ... one of the pharmaceutical players in the field. And that included their lead asset ...

BioAge licensed azelaprag from Amgen in 2021. Thousand Oaks ... It is chasing after Vertex Pharma’s VX-548, which also targets NaV1.8 and last month showed efficacy in a pair of phase 3 trials ...

MaxLinear, the MaxLinear logo, any other MaxLinear trademarks are all property ... or negative impacts from, third parties. Amgen and Kyowa Kirin Co., Ltd. (Kyowa Kirin, TSE: 4151) today announced new ...

We recently published a list of the 11 Best Pharma Stocks to Buy According to Hedge Funds. In this article, we are going to take a look at where Amgen Inc. (NASDAQ:AMGN) stands against the other ...

We recently compiled a list of the 15 Best Biotech Stocks to Buy According to Billionaires. In this article, we are going to ...

The appeals court for the Federal Circuit upheld a lower court’s ruling, finding that Regeneron has not sufficiently ...

Regeneron Pharmaceuticals (REGN) appealed a decision of the United States District Court for the Northern District of West Virginia denying ...

We recently compiled a list of the 10 Cheap Pharmaceutical Stocks to Buy According to Analysts. In this article, we are going to take a look at where Amgen Inc. (NASDAQ:AMGN) stands against the ...

EDT Regeneron (REGN) down 3% after appeals court decision in Amgen (AMGN) patent fightLight Up your Portfolio with Spark:Easily identify ...